3-((3R,8R,9S,10R,13S,14S)-3-((3S,8R,9S,10R,13S,14S)-2,3,4,5,8,9,10,11,12,13,14,15-Dodecahydro-10,13-dimethyl-17-(pyridin-3-yl)-1H-cyclopenta[a]phenanthren-3-yloxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-10,13-dimethyl-1H-cyclopenta[a]phenanthren-17-yl)pyridine | CAS NA | Impurity Reference Standard | Spectrasynth

3-((3R,8R,9S,10R,13S,14S)-3-((3S,8R,9S,10R,13S,14S)-2,3,4,5,8,9,10,11,12,13,14,15-Dodecahydro-10,13-dimethyl-17-(pyridin-3-yl)-1H-cyclopenta[a]phenanthren-3-yloxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-10,13-dimethyl-1H-cyclopenta[a]phenanthren-17-yl)pyridine — Impurity Reference Standard

Buy 3-((3R,8R,9S,10R,13S,14S)-3-((3S,8R,9S,10R,13S,14S)-2,3,4,5,8,9,10,11,12,13,14,15-Dodecahydro-10,13-dimethyl-17-(pyridin-3-yl)-1H-cyclopenta[a]phenanthren-3-yloxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-10,13-dimethyl-1H-cyclopenta[a]phenanthren-17-yl)pyridine (CAS NA) impurity reference standard from Spectrasynth Pharmachem. Custom synthesis available — enquire for pricing, COA and availability.